Financial reports
10-K
2023 FY
Annual report
14 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
27 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
7 Mar 22
Current reports
8-K
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
14 Mar 24
8-K
Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
7 Feb 24
8-K
Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Updates
14 Nov 23
8-K
Amendments to Articles of Incorporation or Bylaws
10 Oct 23
8-K
Terns Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Updates
8 Aug 23
8-K
Terns Pharmaceuticals Announces Leadership Transition
3 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 23
8-K
Entry into a Material Definitive Agreement
15 May 23
8-K
Terns Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Updates
15 May 23
8-K
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates
27 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
14 Mar 24
S-8
Registration of securities for employees
14 Nov 23
S-8
Registration of securities for employees
15 May 23
424B5
Prospectus supplement for primary offering
15 May 23
S-3
Shelf registration
1 Feb 23
424B5
Prospectus supplement for primary offering
21 Dec 22
424B5
Prospectus supplement for primary offering
20 Dec 22
S-8
Registration of securities for employees
9 Nov 22
424B5
Prospectus supplement for primary offering
12 Aug 22
FWP
Free writing prospectus
12 Aug 22
Other
UPLOAD
Letter from SEC
12 Jul 23
CORRESP
Correspondence with SEC
29 Jun 23
UPLOAD
Letter from SEC
22 Jun 23
EFFECT
Notice of effectiveness
13 Feb 23
CORRESP
Correspondence with SEC
8 Feb 23
UPLOAD
Letter from SEC
7 Feb 23
EFFECT
Notice of effectiveness
15 Mar 22
CORRESP
Correspondence with SEC
10 Mar 22
UPLOAD
Letter from SEC
10 Mar 22
EFFECT
Notice of effectiveness
5 Feb 21
Ownership
4
Change in insider ownership
3 Apr 24
144
Notice of proposed sale of securities
3 Apr 24
144
Notice of proposed sale of securities
3 Apr 24
144
Notice of proposed sale of securities
3 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
3
Emil Kuriakose
19 Mar 24
SC 13G
Point72 Asset Management, L.P.
7 Mar 24
4
Amy L. Burroughs
5 Mar 24